We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Article |

Use of Fibrinolysin (Thrombolysin) in Isolated Limb Perfusion to Dissolve Arterial Thrombi

Arch Surg. 1962;84(1):34-40. doi:10.1001/archsurg.1962.01300190038006.
Text Size: A A A
Published online


Introduction  Surgical therapy in the management of acute peripheral arterial obstruction is often unsatisfactory, due to distal propagation of the thrombus or thrombosis of vital collateral channels. Drugs are available at the present time which will lyse fresh vascular thrombi. Although confusion exists as to which enzyme is the preferred clot-lysing agent, fibrinolysin (plasmin) has been demonstrated to be effective in many experimental and clinical conditions.1,3,6 Evidence is accumulating, however, which indicates that some sort of local administration is necessary for fibrinolysin to be effective within its toxic limitation.Boyles2 has shown that intra-arterial administration of fibrinolysin is necessary for the lysis of coronary and carotid artery thrombosis. Cliffton3 has obtained more effective results in the treatment of acute thromboembolism in humans by the direct injection of fibrinolysin. Ouchi7 claims dissolution of clots up to 7 days in age by the local administration of fibrinolysin.Kierle


Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

First Page Preview

View Large
First page PDF preview





Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.


Some tools below are only available to our subscribers or users with an online account.

0 Citations

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

Related Content

Customize your page view by dragging & repositioning the boxes below.